Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yandong Su

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Entropy (Basel, Switzerland)|July 29, 2025
Post-Quantum Secure Multi-Factor Authentication Protocol for Multi-Server ArchitectureYunhua Wen, Yandong Su, Wei Li
Cancer Control : Journal of the Moffitt Cancer Center|December 13, 2023
Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal MesotheliomaYue Chen, Xuemei Du, Ying Gao, et al.
Cancer Biology & Medicine|July 19, 2024
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritoneiQidi Zhao, Tian Wei, Ru Ma, et al.
World Neurosurgery|February 14, 2017
Microsurgical Outcomes After Gross Total Resection on Vestibular Schwannoma in Elderly Patients: A Matched Cohort StudyNian Jiang, Zaibin Wang, Wen Chen, et al.
International Journal of Oncology|July 20, 2022
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)Tianzhen Hua, Huanxiao Shi, Mengmei Zhu, et al.
Journal of Cancer|October 22, 2019
Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma PatientsNingrong Ye, Nian Jiang, Chengyuan Feng, et al.
Frontiers in Immunology|July 15, 2024
AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathwaysShuai Zhang, Lilin Cheng, Yandong Su, et al.
Frontiers in Medicine|August 14, 2023
Analysis of risk factors and short-term prognostic factors of arrhythmia in patients infected with mild/moderate SARS-CoV-2 Omicron variantLijie Yan, Jintao Wu, Xianwei Fan, et al.
Cancer Biology & Medicine|November 1, 2024
Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapyHeliang Wu, Yi Wang, Yulin Lin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Entropy (Basel, Switzerland)|July 29, 2025
Post-Quantum Secure Multi-Factor Authentication Protocol for Multi-Server ArchitectureYunhua Wen, Yandong Su, Wei Li
Cancer Control : Journal of the Moffitt Cancer Center|December 13, 2023
Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal MesotheliomaYue Chen, Xuemei Du, Ying Gao, et al.
Cancer Biology & Medicine|July 19, 2024
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritoneiQidi Zhao, Tian Wei, Ru Ma, et al.
World Neurosurgery|February 14, 2017
Microsurgical Outcomes After Gross Total Resection on Vestibular Schwannoma in Elderly Patients: A Matched Cohort StudyNian Jiang, Zaibin Wang, Wen Chen, et al.
International Journal of Oncology|July 20, 2022
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)Tianzhen Hua, Huanxiao Shi, Mengmei Zhu, et al.
Journal of Cancer|October 22, 2019
Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma PatientsNingrong Ye, Nian Jiang, Chengyuan Feng, et al.
Frontiers in Immunology|July 15, 2024
AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathwaysShuai Zhang, Lilin Cheng, Yandong Su, et al.
Frontiers in Medicine|August 14, 2023
Analysis of risk factors and short-term prognostic factors of arrhythmia in patients infected with mild/moderate SARS-CoV-2 Omicron variantLijie Yan, Jintao Wu, Xianwei Fan, et al.
Cancer Biology & Medicine|November 1, 2024
Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapyHeliang Wu, Yi Wang, Yulin Lin, et al.
Pageof 1